Nephros Inc
NASDAQ:NEPH
Intrinsic Value
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. [ Read More ]
The intrinsic value of one NEPH stock under the Base Case scenario is 1.23 USD. Compared to the current market price of 1.99 USD, Nephros Inc is Overvalued by 38%.
Valuation Backtest
Nephros Inc
Run backtest to discover the historical profit from buying and selling NEPH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Nephros Inc
Current Assets | 8.4m |
Cash & Short-Term Investments | 4.3m |
Receivables | 1.5m |
Other Current Assets | 2.6m |
Non-Current Assets | 3.5m |
PP&E | 2m |
Intangibles | 1.4m |
Other Non-Current Assets | 86k |
Current Liabilities | 2.1m |
Accounts Payable | 873k |
Accrued Liabilities | 1.2m |
Non-Current Liabilities | 1.4m |
Other Non-Current Liabilities | 1.4m |
Earnings Waterfall
Nephros Inc
Revenue
|
14.2m
USD
|
Cost of Revenue
|
-5.8m
USD
|
Gross Profit
|
8.4m
USD
|
Operating Expenses
|
-10m
USD
|
Operating Income
|
-1.6m
USD
|
Other Expenses
|
18k
USD
|
Net Income
|
-1.6m
USD
|
Free Cash Flow Analysis
Nephros Inc
What is Free Cash Flow?
NEPH Profitability Score
Profitability Due Diligence
Nephros Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
Score
Nephros Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
NEPH Solvency Score
Solvency Due Diligence
Nephros Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Score
Nephros Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NEPH Price Targets Summary
Nephros Inc
According to Wall Street analysts, the average 1-year price target for NEPH is 4.85 USD with a low forecast of 4.55 USD and a high forecast of 5.25 USD.
Ownership
NEPH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
NEPH Price
Nephros Inc
Average Annual Return | 0.15% |
Standard Deviation of Annual Returns | 85.38% |
Max Drawdown | -92% |
Market Capitalization | 21m USD |
Shares Outstanding | 10 544 100 |
Percentage of Shares Shorted | 0.04% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.
Contact
IPO
Employees
Officers
The intrinsic value of one NEPH stock under the Base Case scenario is 1.23 USD.
Compared to the current market price of 1.99 USD, Nephros Inc is Overvalued by 38%.